678 related articles for article (PubMed ID: 19619898)
1. Clinical effectiveness of oseltamivir for influenza A(H1N1) virus with H274Y neuraminidase mutation.
Kawai N; Ikematsu H; Iwaki N; Kondou K; Hirotsu N; Kawashima T; Maeda T; Tanaka O; Doniwa K; Kashiwagi S
J Infect; 2009 Sep; 59(3):207-12. PubMed ID: 19619898
[TBL] [Abstract][Full Text] [Related]
2. Clinical effectiveness of oseltamivir and zanamivir for treatment of influenza A virus subtype H1N1 with the H274Y mutation: a Japanese, multicenter study of the 2007-2008 and 2008-2009 influenza seasons.
Kawai N; Ikematsu H; Hirotsu N; Maeda T; Kawashima T; Tanaka O; Yamauchi S; Kawamura K; Matsuura S; Nishimura M; Iwaki N; Kashiwagi S
Clin Infect Dis; 2009 Dec; 49(12):1828-35. PubMed ID: 19911968
[TBL] [Abstract][Full Text] [Related]
3. Emergence of H274Y oseltamivir-resistant A(H1N1) influenza viruses in Japan during the 2008-2009 season.
Baranovich T; Saito R; Suzuki Y; Zaraket H; Dapat C; Caperig-Dapat I; Oguma T; Shabana II; Saito T; Suzuki H;
J Clin Virol; 2010 Jan; 47(1):23-8. PubMed ID: 19962344
[TBL] [Abstract][Full Text] [Related]
4. Rapid identification of oseltamivir-resistant influenza A(H1N1) viruses with H274Y mutation by RT-PCR/restriction fragment length polymorphism assay.
Guo L; Garten RJ; Foust AS; Sessions WM; Okomo-Adhiambo M; Gubareva LV; Klimov AI; Xu X
Antiviral Res; 2009 Apr; 82(1):29-33. PubMed ID: 19428592
[TBL] [Abstract][Full Text] [Related]
5. Genetic microheterogeneity of emerging H275Y influenza virus A (H1N1) in Toronto, Ontario, Canada from the 2007-2008 respiratory season.
Eshaghi A; Bolotin S; Burton L; Low DE; Mazzulli T; Drews SJ
J Clin Virol; 2009 Jun; 45(2):142-5. PubMed ID: 19451021
[TBL] [Abstract][Full Text] [Related]
6. Effect of the neuraminidase mutation H274Y conferring resistance to oseltamivir on the replicative capacity and virulence of old and recent human influenza A(H1N1) viruses.
Baz M; Abed Y; Simon P; Hamelin ME; Boivin G
J Infect Dis; 2010 Mar; 201(5):740-5. PubMed ID: 20100088
[TBL] [Abstract][Full Text] [Related]
7. Genotypic and phenotypic resistance of pandemic A/H1N1 influenza viruses circulating in Germany.
Duwe SC; Wedde M; Birkner P; Schweiger B
Antiviral Res; 2011 Jan; 89(1):115-8. PubMed ID: 21070812
[TBL] [Abstract][Full Text] [Related]
8. Reduced effectiveness of oseltamivir in children infected with oseltamivir-resistant influenza A (H1N1) viruses with His275Tyr mutation.
Saito R; Sato I; Suzuki Y; Baranovich T; Matsuda R; Ishitani N; Dapat C; Dapat IC; Zaraket H; Oguma T; Suzuki H
Pediatr Infect Dis J; 2010 Oct; 29(10):898-904. PubMed ID: 20442686
[TBL] [Abstract][Full Text] [Related]
9. Detection of the rapid emergence of the H275Y mutation associated with oseltamivir resistance in severe pandemic influenza virus A/H1N1 09 infections.
Wang B; Dwyer DE; Blyth CC; Soedjono M; Shi H; Kesson A; Ratnamohan M; McPhie K; Cunningham AL; Saksena NK
Antiviral Res; 2010 Jul; 87(1):16-21. PubMed ID: 20385168
[TBL] [Abstract][Full Text] [Related]
10. A two-year survey of the oseltamivir-resistant influenza A(H1N1) virus in Yamagata, Japan and the clinical effectiveness of oseltamivir and zanamivir.
Matsuzaki Y; Mizuta K; Aoki Y; Suto A; Abiko C; Sanjoh K; Sugawara K; Takashita E; Itagaki T; Katsushima Y; Ujike M; Obuchi M; Odagiri T; Tashiro M
Virol J; 2010 Mar; 7():53. PubMed ID: 20202225
[TBL] [Abstract][Full Text] [Related]
11. Oseltamivir-resistant pandemic A(H1N1) 2009 influenza viruses detected through enhanced surveillance in the Netherlands, 2009-2010.
Meijer A; Jonges M; Abbink F; Ang W; van Beek J; Beersma M; Bloembergen P; Boucher C; Claas E; Donker G; van Gageldonk-Lafeber R; Isken L; de Jong A; Kroes A; Leenders S; van der Lubben M; Mascini E; Niesters B; Oosterheert JJ; Osterhaus A; Riesmeijer R; Riezebos-Brilman A; Schutten M; Sebens F; Stelma F; Swaan C; Timen A; van 't Veen A; van der Vries E; te Wierik M; Koopmans M
Antiviral Res; 2011 Oct; 92(1):81-9. PubMed ID: 21767571
[TBL] [Abstract][Full Text] [Related]
12. Surveillance for neuraminidase-inhibitor-resistant influenza viruses in Japan, 1996-2007.
Tashiro M; McKimm-Breschkin JL; Saito T; Klimov A; Macken C; Zambon M; Hayden FG;
Antivir Ther; 2009; 14(6):751-61. PubMed ID: 19812437
[TBL] [Abstract][Full Text] [Related]
13. Detection of human influenza A (H1N1) and B strains with reduced sensitivity to neuraminidase inhibitors.
Escuret V; Frobert E; Bouscambert-Duchamp M; Sabatier M; Grog I; Valette M; Lina B; Morfin F; Ferraris O
J Clin Virol; 2008 Jan; 41(1):25-8. PubMed ID: 18055253
[TBL] [Abstract][Full Text] [Related]
14. Surveillance and oseltamivir resistance of human influenza a virus in Turkey during the 2007-2008 season.
Ciblak MA; Hasoksuz M; Escuret V; Valette M; Gul F; Yilmaz H; Turan N; Bozkaya E; Badur S
J Med Virol; 2009 Sep; 81(9):1645-51. PubMed ID: 19626608
[TBL] [Abstract][Full Text] [Related]
15. Early findings of oseltamivir-resistant pandemic (H1N1) 2009 influenza A viruses in Taiwan.
Yang JR; Huang YP; Lin YC; Su CH; Kuo CY; Hsu LC; Wu HS; Liu MT
Antiviral Res; 2010 Dec; 88(3):256-62. PubMed ID: 20869989
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the clinical effectiveness of oseltamivir and zanamivir against influenza virus infection in children.
Sugaya N; Tamura D; Yamazaki M; Ichikawa M; Kawakami C; Kawaoka Y; Mitamura K
Clin Infect Dis; 2008 Aug; 47(3):339-45. PubMed ID: 18582202
[TBL] [Abstract][Full Text] [Related]
17. Activity of the neuraminidase inhibitor A-315675 against oseltamivir-resistant influenza neuraminidases of N1 and N2 subtypes.
Abed Y; Nehmé B; Baz M; Boivin G
Antiviral Res; 2008 Feb; 77(2):163-6. PubMed ID: 17919743
[TBL] [Abstract][Full Text] [Related]
18. Insights from investigating the interaction of oseltamivir (Tamiflu) with neuraminidase of the 2009 H1N1 swine flu virus.
Wang SQ; Du QS; Huang RB; Zhang DW; Chou KC
Biochem Biophys Res Commun; 2009 Aug; 386(3):432-6. PubMed ID: 19523442
[TBL] [Abstract][Full Text] [Related]
19. Different neuraminidase inhibitor susceptibilities of human H1N1, H1N2, and H3N2 influenza A viruses isolated in Germany from 2001 to 2005/2006.
Bauer K; Richter M; Wutzler P; Schmidtke M
Antiviral Res; 2009 Apr; 82(1):34-41. PubMed ID: 19428593
[TBL] [Abstract][Full Text] [Related]
20. Recovery of a multidrug-resistant strain of pandemic influenza A 2009 (H1N1) virus carrying a dual H275Y/I223R mutation from a child after prolonged treatment with oseltamivir.
Nguyen HT; Fry AM; Loveless PA; Klimov AI; Gubareva LV
Clin Infect Dis; 2010 Oct; 51(8):983-4. PubMed ID: 20858074
[No Abstract] [Full Text] [Related]
[Next] [New Search]
